Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
Abstract Objectives Serum neurofilament light chain (sNfL) is a promising biomarker of MS activity, progression, and treatment response. The aim of the present study was to address whether sNfL concentrations are affected by supplementation of vitamin D and correlate with disease activity in interfe...
Main Authors: | Katariina Hänninen, Olli Jääskeläinen, Sanna‐Kaisa Herukka, Merja Soilu‐Hänninen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.1772 |
Similar Items
-
Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
by: Katariina Hänninen, et al.
Published: (2020-07-01) -
Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI
by: Mette Heiskanen, et al.
Published: (2022-12-01) -
Circulating neurofilament is linked with morbid obesity, renal function, and brain density
by: Eleni Rebelos, et al.
Published: (2022-05-01) -
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
by: Simon Thebault, et al.
Published: (2021-03-01) -
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis
by: Antti Cajanus, et al.
Published: (2020-06-01)